ACE and type 2 diabetes mellitus: In conclusion, sitagliptin use was associated with an increased risk of HHF inpatients with T2DM receiving dialysis, especially in those without severehypoglycemia, without ACE inhibitors treatment, with prior heart failure orreceiving hemodialysis.